capsuflex 300 mg/100 mg/100 mcg capsule
euro-health care exponents, inc.; distributor: vitalink health products, inc. - vitamin b1 , b6 , b12 - capsule - 300 mg/100 mg/100 mcg
none 125 mg/6.25mg/500 mcg per 5 ml syrup
euro-health care exponents, inc.; distributor: pacific pharmaceutical generic, inc. - paracetamol , phenylephrine hydrochloride , chlorphenamine maleate - syrup - 125 mg/6.25mg/500 mcg per 5 ml
heralink capsule
euro-health care exponents, inc.; distributor: hei gruppo pharmaceutica, inc. - multivitamins , iron - capsule - (see reverse for formulation)
dallefer-fa capsule
euro-health care exponents, inc.; distributor: gdalle essential drug, inc. - multivitamins , iron - capsule - (see reverse for formulation)
stero-cort 20 20 mg film-coated tablet
euro-health care exponents, inc.; distributor: 999 seth pharmaceuticals, inc. - prednisone - film-coated tablet - 20 mg
fuvixin 2% cream
euro-health care exponents, inc.; distributor: vitalink health products, inc. - fusidic acid - cream - 2%
sincalide injection, powder, lyophilized, for solution
maia pharmaceuticals, inc. - sincalide (unii: m03giq7z6p) (sincalide - unii:m03giq7z6p) - sincalide for injection is indicated in adults to: - stimulate gallbladder contraction, as may be assessed by various methods of diagnostic imaging, or to obtain by duodenal aspiration a sample of concentrated bile for analysis of cholesterol, bile salts, phospholipids, and crystals; - stimulate pancreatic secretion in combination with secretin prior to obtaining a duodenal aspirate for analysis of enzyme activity, composition, and cytology; - accelerate the transit of a barium meal through the small bowel, thereby decreasing the time and extent of radiation associated with fluoroscopy and x-ray examination of the intestinal tract. sincalide for injection is contraindicated in patients with: - a history of a hypersensitivity reaction to sulfites or sincalide. serious hypersensitivity reactions have included anaphylaxis and anaphylactic shock [see warnings and precautions (5.1), adverse reactions (6)]. - intestinal obstruction. risk summary based on limited human data and mechanism of action, sincalide for inj
sincalide injection, powder, lyophilized, for solution
fosun pharma usa inc - sincalide (unii: m03giq7z6p) (sincalide - unii:m03giq7z6p) - sincalide for injection is indicated in adults to: - stimulate gallbladder contraction, as may be assessed by various methods of diagnostic imaging, or to obtain by duodenal aspiration a sample of concentrated bile for analysis of cholesterol, bile salts, phospholipids, and crystals; - stimulate pancreatic secretion in combination with secretin prior to obtaining a duodenal aspirate for analysis of enzyme activity, composition, and cytology; - accelerate the transit of a barium meal through the small bowel, thereby decreasing the time and extent of radiation associated with fluoroscopy and x-ray examination of the intestinal tract. sincalide for injection is contraindicated in patients with: - a history of a hypersensitivity reaction to sincalide. serious hypersensitivity reactions have included anaphylaxis and anaphylactic shock [see warnings and precautions (5.1), adverse reactions (6)]. - intestinal obstruction. risk summary based on limited human data and mechanism of action, sincalide for
galzin- zinc acetate capsule
teva pharmaceuticals usa, inc. - zinc acetate (unii: fm5526k07a) (zinc cation - unii:13s1s8sf37) - zinc cation 25 mg - zinc acetate therapy is indicated for maintenance treatment of patients with wilson’s disease who have been initially treated with a chelating agent (see precautions: monitoring patients). zinc acetate capsules are contraindicated in patients with known hypersensitivity to any of the components of the formulation.
zinc ointment
alliance healthcare (distribution) ltd - zinc oxide - cutaneous ointment - 150mg/1gram